<SEC-DOCUMENT>0001104659-22-084778.txt : 20220801
<SEC-HEADER>0001104659-22-084778.hdr.sgml : 20220801
<ACCEPTANCE-DATETIME>20220801171058
ACCESSION NUMBER:		0001104659-22-084778
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220801
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220801
DATE AS OF CHANGE:		20220801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		221125698

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		(215) 921-7600

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2222250d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:fold="http://amicustherapeutics.com/20220801">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_fold_amicustherapeutics.com_20220801 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20220801_20220801 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001178879 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityCentralIndexKey">0001178879</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fold-20220801.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-08-01to2022-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2022-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>UNITED
STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>WASHINGTON,
D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b></b>&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20220801__20220801_zp0O7aPx3t31"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>CURRENT
REPORT PURSUANT TO</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECTION
13 OR 15(d) OF THE</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Date of Report (Date of
earliest event reported):&#160;<b><span id="xdx_909_edei--DocumentPeriodEndDate_c20220801__20220801_zapmNjh51o99"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 1, 2022</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20220801__20220801_zVW2EJpIVuh5"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityRegistrantName">AMICUS THERAPEUTICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Exact
Name of Registrant as Specified in  Its Charter)</p>

<p style="font-size: 10pt; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center; width: 32%"><b><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220801__20220801_zIX1HYywYxic"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></td>
    <td style="padding: 2px; text-align: left; width: 2%"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center; width: 32%"><span id="xdx_90D_edei--EntityFileNumber_c20220801__20220801_z7yUweP9af4e" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityFileNumber">001-33497</ix:nonNumeric></span></td>
    <td style="padding: 2px; text-align: left; width: 2%"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center; width: 32%"><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20220801__20220801_zFSkRxEwe2b" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityTaxIdentificationNumber">71-0869350</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(State
                                            or Other Jurisdiction</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>of Incorporation)</b></span></p></td>
    <td style="padding: 2px; text-align: center"><span style="font-style: normal"><b>&#160;</b></span></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(Commission</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>File Number)</b></span></p></td>
    <td style="padding: 2px; text-align: center"><span style="font-style: normal"><b>&#160;</b></span></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>(I.R.S.
                                            Employer</b></span></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-style: normal"><b>Identification No.)</b></span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 192px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 192px; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_903_edei--EntityAddressAddressLine1_c20220801__20220801_zpwLcMLORqT3"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityAddressAddressLine1">3675 Market Street</ix:nonNumeric></span>,
<span id="xdx_90A_edei--EntityAddressCityOrTown_c20220801__20220801_z9ksrQSrAQLa"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20220801__20220801_zs2w2Tq1FMZ"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20220801__20220801_zSQ3QV3XL5z"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:EntityAddressPostalZipCode">19104</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(Address of Principal
Executive Offices, and Zip Code)</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_909_edei--CityAreaCode_c20220801__20220801_znjRCtVWxoo9"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:CityAreaCode">215</ix:nonNumeric></span>-<span id="xdx_90C_edei--LocalPhoneNumber_c20220801__20220801_zI2Vx8aDtk2g"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:LocalPhoneNumber">921-7600</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Registrant&#8217;s
Telephone Number, Including Area Code</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report.)</p>

<p style="font-size: 10pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-left: 0.75in; font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90B_edei--WrittenCommunications_c20220801__20220801_z84MhBVI5bc5"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_902_edei--SolicitingMaterial_c20220801__20220801_zy25uEAfgxs9"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20220801__20220801_zCD5IkVCkb8"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20220801__20220801_zHyXAvsMARCh"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant
to Section 12(b) of the Act:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="border: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 40%"><span style="font: normal 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 20%"><span style="font: normal 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 2px; padding-right: 2px; padding-left: 2px; text-align: center; width: 40%"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Times New Roman, Times, Serif">Name
                                            of each exchange on which registered</span></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_c20220801__20220801_z1RAu6kTATAk"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:Security12bTitle">Common Stock Par Value $0.01</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--TradingSymbol_c20220801__20220801_zxzF6kbPLnci"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" name="dei:TradingSymbol">FOLD</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--SecurityExchangeName_c20220801__20220801_z7c1UWYOpz8g"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR &#167;240.12b-2). Emerging growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20220801__20220801_ztmoth0E6QX" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2022-08-01to2022-08-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></p>

<p style="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>Item 5.02. &#8211; Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Bradley L. Campbell</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">As
previously announced by Amicus Therapeutics, Inc. (the &#8220;Company&#8221;) on February 24, 2022, Bradley L. Campbell, who has served
as a member of the Company&#8217;s board of directors (the &#8220;Board&#8221;) since June&#160;2018 and as President and Chief Operating
Officer since January&#160;2015, and Chief Operating Officer since December&#160;2013, has been appointed Chief Executive Officer of the
Company. Mr. Campbell, 47, joined Amicus in 2006. Mr. Campbell currently serves on a number of boards of directors, including Gennao
Bio, the Alliance for Regenerative Medicine (ARM), and the Corporate Advisory Board for the National Tay-Sachs and Allied Diseases Association.
He previously served on the Board of ARYA Sciences Acquisition Corp III, a healthcare focused special purpose acquisition vehicle, as
well as Progenics Pharmaceuticals (NASDAQ: PGNX) from 2016 until its successful acquisition by Lantheus Holdings in 2020. Prior to working
at the Company, Mr. Campbell spent time in various commercial and business development roles at Genzyme and Bristol-Myers Squibb and as
a strategy consultant for Marakon Associates. He received a B.A. in Public Policy Studies from Duke University and an M.B.A. from Harvard
Business School.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">On
August 1, 2022, Mr. Campbell entered into an employment agreement with the Company (the &#8220;CEO Employment Agreement&#8221;) pursuant
to which Mr. Campbell will serve as the Chief Executive Officer of the Company beginning on August 1, 2022 until Mr. Campbell&#8217;s
employment is terminated by either Mr. Campbell or the Company. The CEO Employment Agreement supersedes Mr. Campbell&#8217;s prior employment
agreement with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">Under
the terms of the CEO Employment Agreement, Mr. Campbell will be (i) entitled to an initial annual base salary of $625,000; (ii) eligible
to receive an annual target of 100% of his base salary in cash, such actual amount determined by the Company Compensation and Leadership
Development Committee in its absolute discretion and at 60% of base salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">The
CEO Employment Agreement provides that if Mr. Campbell&#8217;s employment is terminated for any reason, Mr. Campbell will be entitled
to (1) all accrued but unpaid base salary, (2) unreimbursed expenses and (3) other accrued obligations under the Company&#8217;s employee
plans ((1)-(3), collectively, &#8220;CEO Accrued Amounts&#8221;). If Mr. Campbell&#8217;s employment is terminated by the Company without
Cause (as defined in the CEO Employment Agreement) and not within 12 months after a &#8220;Change in Control Event&#8221; (as defined
in the CEO Employment Agreement), Mr. Campbell will be entitled to (1) the CEO Accrued Amounts, (2) payment of an amount equal to his
then current base salary (generally payable over 18 months following termination), (3) payment of a bonus equal to 150% of the target
bonus for the calendar year in which such termination occurs pro-rated for the number of days actually worked in the year of termination
(generally payable within 75 days following termination), (4) the accelerated vesting of any Company stock options and restricted Company
stock units held by Mr. Campbell that were scheduled to vest within 18 months following such termination and (5) the continuation of employee
benefits plans for a period of 18 months after the date of termination ((2)-(5), collectively, the &#8220;CEO Severance Benefits&#8221;).
Under the terms of the CEO Employment Agreement, if Mr. Campbell&#8217;s employment is terminated by the Company without Cause or by Mr.
Campbell for Good Reason (as defined in the agreement) within 12 months of a Change in Control Event (as defined in the agreement), Mr.
Campbell will be entitled to (1) the CEO Accrued Amounts and (2) payment of an amount equal to 2 times his then current base salary (generally
payable over 24 months following termination), (3) a lump sum payment of an amount equal to 200% of the target bonus for the calendar
year in which such termination occurs (generally payable within 75 days following termination), (4) the accelerated vesting of any Amicus
stock options and restricted stock grants held by Mr.&#160;Campbell; and (5) the continuation of employee benefits plans for a period
of 24 months after the date of termination ((2)-(5), collectively, the &#8220;CEO Change in Control Severance Benefits&#8221;). The payment
of CEO Severance Benefits or CEO Change in Control Severance Benefits, as applicable, are contingent on Mr. Campbell signing and not revoking
a release of claims in favor of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">The
foregoing description of the CEO Employment Agreement does not purport to be complete and is qualified in its entirety by the terms and
conditions of the CEO Employment Agreement, which is attached hereto as Exhibit 10.1 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">As
previously disclosed, Mr. Campbell also previously received a one-time promotion grant of Company equity valued at $2 million,
comprised of 50% Company stock options and 50% restricted stock units, which will vest (subject to continued employment) in
accordance with the terms and conditions of the applicable Company equity plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no family relationships between Mr.&#160;Campbell
and any director or executive officer of the Company, and Mr. Campbell has no indirect material interest in any transaction required to
be disclosed pursuant to Item 404(a)&#160;of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>John F. Crowley</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As previously announced by the Company on
February 24, 2022, effective August 1, 2022, John F. Crowley, who has served as a Director, Chairman and Chief Executive Officer of
the Company since February 2010 and Chief Executive Officer since January 2005 (except for a period from April 2011 through August
2011 during which time he served as Executive Chairman), will transition to the role of Executive Chair of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with Mr. Crowley&#8217;s Executive
Chair appointment, on February 23, 2022, Mr. Crowley entered into a new employment agreement with the Company (the &#8220;Executive Chair
Agreement&#8221;). The Executive Chair Agreement became effective on August 1, 2022 and supersedes Mr. Crowley&#8217;s prior employment
agreement with the Company e. A copy of the Executive Chair Agreement was attached to the Company&#8217;s Current Report on Form 8-K,
filed on February 24, 2022, as Exhibit 10.2 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>(d) Exhibits:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; text-align: center"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 78%; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><a href="tm2222250d1_10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom"><a href="tm2222250d1_10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Employment Agreement, dated August 1, 2022, by and between the Company and Bradley L. Campbell</span></a></td></tr>
  <tr>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/1178879/000110465922026330/tm227309d2_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom"><a href="https://www.sec.gov/Archives/edgar/data/1178879/000110465922026330/tm227309d2_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Employment Agreement, dated February 23, 2022, by and between the Company and John F. Crowley (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 24, 2022)</span></a></td></tr>
  <tr>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration: underline">Signature Page</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: center; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 0.25in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: 0.25in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">AMICUS THERAPEUTICS, INC.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%"><span style="font-size: 10pt">Date: August 1, 2022</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 47%"><span style="font-size: 10pt">/s/ Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">Name: Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">Title: Chief Legal Officer and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk0KovbRokWsIkXE19iuEmyzZRP/juQtjS3isrAsM9+MEAOR0dLUyHCcFznssWlr7REKPCOjLTE40tU6gXALvBjnWVvfvT8wpcBgYMZDeSqD0FnvxmGVgJyO5GSkZiBniVKw24joq6dkz6ZC642uQdsKdkwtG/SaX33CXj/JUvPqqg7IzpBNQA1lL78hliqGLd31g/jqIM9TEQ26iUTGdGu/NTfnqYFFjU3ocj363+gDPyxJhA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2222250d1_10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

                           <P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>EMPLOYMENT AGREEMENT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>THIS EMPLOYMENT AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;),
dated as of August 1<SUP>st</SUP>, 2022 (the &ldquo;<U>Effective Date</U>&rdquo;), between AMICUS THERAPEUTICS, INC., a Delaware corporation
having an office at 3675 Market Street, Philadelphia, PA 19104 (the &ldquo;<U>Company</U>&rdquo;), and Bradley Campbell, an individual
residing at [&hellip;], (&ldquo;<U>Employee</U>&rdquo;) (together, the &ldquo;<U>parties</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>WHEREAS,</B> the Company wishes to <B>continue
to</B> employ Employee, and Employee wishes to <B>continue to</B> be employed by Company, on the terms and conditions set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>NOW, THEREFORE,</B> in consideration of the mutual
covenants contained herein, and for other good and valuable consideration, the sufficiency and receipt whereof is hereby acknowledged,
the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definitions</U>. Unless otherwise defined herein, the following terms shall have the following respective meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Accrued Amounts</U>&rdquo; means, as of
the termination of Employee&rsquo;s employment: (a)&nbsp;the total of any expenses properly incurred by Employee under Section 3.4(b)
that have not previously been reimbursed as of the effective date of the termination; (b)&nbsp;the sum of Employee&rsquo;s accrued, but
unused, vacation time, if any, as of the effective date of the termination; and (c) any accrued and unpaid Base Salary through and including
the effective date of Employee&rsquo;s termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo; shall mean any other
company, directly or indirectly, controlling, controlled by or under common control with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Cause</U>&rdquo; means
Employee&rsquo;s: (i)&nbsp;willful or deliberate misconduct that has or could reasonably be expected to have a materially adverse
impact on the reputation or business of the Company (or an Affiliate), or that results in gain or personal enrichment of Employee to
the detriment of the Company (or an Affiliate); (ii)&nbsp;violation of Company policy including, but not limited to, policies
prohibiting harassment and other workplace misconduct, and policies governing corporate compliance; (iii) misappropriation of the
funds or assets of the Company (or an Affiliate); (iv) conviction, plea of guilty, admission to facts sufficient for a finding of
guilt, or plea of no contest (or nolo contendere) to: (a) any felony, or (b) any misdemeanor involving fraud, theft, dishonesty,
wrongful taking of property, embezzlement, bribery, forgery or extortion; (v) material breach of this Agreement; (vi)&nbsp;material
breach of the Confidentiality, Non-Disclosure and Non-Competition Agreement attached as <U>Exhibit A</U>; (vii) breach of
Employee&rsquo;s duty of loyalty to the Company; (viii) disqualification, bar or suspension by any governmental authority from
performing any of the duties contemplated by this Agreement; (ix)&nbsp;material failure to perform Employee&rsquo;s duties or
obligations hereunder (other than as a result of being Unable to Work); or (x)&nbsp;willful failure to adhere to or carry out lawful
duties or directives of the Company&rsquo;s Board of Directors (&ldquo;<U>Board</U>&rdquo;). Notwithstanding anything to the
contrary herein, the Company shall not be deemed to have terminated Employee for Cause for the events described above in subsections
(ix) or (x) unless the Board has determined that such events are amenable to cure and given Employee written notice of the
occurrence of the claimed event(s) constituting Cause and Employee has failed to cure such event(s) within fourteen (14) calendar
days after Employee&rsquo;s receipt of such notice (or such other period as may be deemed reasonable by the Board under the
circumstances and communicated to Employee). The other events described above are not subject to an opportunity to cure but the
Company may, in its sole discretion, conduct an investigation into those events and provide the employee a full opportunity to
participate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Change in Control Event</U>&rdquo; means
any of the following: (i)&nbsp;when any person or entity who is not currently a stockholder of the Company (as of the date of this Agreement)
becomes the beneficial owner of greater than 50% of the then-outstanding voting power of the Company; (ii)&nbsp;when a merger or consolidation
with another entity occurs that causes the voting securities of the Company outstanding immediately before the transaction to constitute
less than a majority of the voting power of the voting securities of the Company or the surviving entity outstanding immediately after
the transaction; or (iii)&nbsp;when a sale or disposition of all or substantially all of the Company&rsquo;s assets occurs. Notwithstanding
the foregoing, no event shall be deemed to be a Change in Control Event unless such event would also be a Change in Control under Section
409A and the rules and regulations promulgated thereunder (collectively, &ldquo;<U>Section 409</U>&rdquo;) of the Internal Revenue Code
of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;) or would otherwise be a permitted distribution event under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Change in Control Severance Benefits</U>&rdquo;
means: (i) payment of an amount equal to two (2) times Employee&rsquo;s then current Base Salary, payable in installments over twenty-four
(24)&nbsp;months, commencing within sixty (60) calendar days after the resignation or termination (collectively, &ldquo;termination&rsquo;)
of Employee&rsquo;s employment with the Company, in accordance with the Company&rsquo;s customary payroll practices for its senior management
personnel; (ii) payment of an amount equal to 200% of the target Bonus for the calendar year in which such termination occurs (such amount
being payable in a lump sum), payable within seventy five (75) calendar days following such termination ; (iii) the accelerated vesting
of stock options held by Employee immediately prior to such termination (&ldquo;<U>Options</U>&rdquo;), such that all Options will become
vested as of the date of Employee&rsquo;s termination; (iv) the accelerated vesting of restricted stock grants held by Employee immediately
prior to such termination (&ldquo;<U>Grants</U>&rdquo;), such that all Grants will become vested as of the date of Employee&rsquo;s termination;
(v) the accelerated vesting of performance restricted stock units held by Employee immediately prior to such termination at the applicable
performance targets or such greater amounts as determined by the Board of Directors in their sole discretion; and (vi) in the event that
Employee is enrolled in any of the Company&rsquo;s group health benefits plans as of the effective date of Employee&rsquo;s termination,
then Employee and Employee&rsquo;s eligible dependents, if any, shall remain eligible to continue their participation in such plans for
a period of twenty-four (24) months after Employee&rsquo;s date of termination, subject to the eligibility and other terms and conditions
of such plans, except that the Company will pay the full premiums otherwise payable for such coverage during such 24 month period. Notwithstanding
any other provision of this Agreement, Employee&rsquo;s receipt of Change in Control Severance Benefits is conditioned on Employee&rsquo;s
execution and delivery to the Company of a separation agreement (that Employee does not revoke) containing a general release, the form
and substance of which are acceptable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____<U>/s/</U> <U>BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Good Reason</U>&rdquo; means the occurrence
of one or both of the following events without Employee&rsquo;s consent: (i)&nbsp;the Company&rsquo;s material diminution of Employee&rsquo;s
authority, duties, or responsibilities as set forth in this Agreement; or (ii)&nbsp;the Company&rsquo;s change in the principal geographic
location at which Employee provides services to the Company to a location more than thirty (30) miles from Employee&rsquo;s assigned primary
office location, unless such relocation is only temporary, for a reasonable period of time, or unless such relocation merely constitutes
travel reasonably required in connection with the performance of Employee&rsquo;s duties. Notwithstanding anything to the contrary herein,
Employee shall not be deemed to have resigned for Good Reason unless: (a) Employee had provided to the Company written notice within thirty
(30) calendar days of the occurrence of the claimed event(s) constituting Good Reason, specifying in detail the basis for such Good Reason;
(b) the Company fails to cure the Good Reason within thirty (30) calendar days after its receipt of such notice, and (c) Employee terminates
employment within sixty (60) calendar days after providing notice to Company of the claimed event(s) constituting Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Severance Benefits</U>&rdquo; means (i)
payment of an amount equal to Employee&rsquo;s then current Base Salary, payable in installments over eighteen (18)&nbsp;months, commencing
within sixty (60) calendar days of the termination of Employee&rsquo;s employment with the Company, in accordance with the Company&rsquo;s
customary payroll practices then in effect for its senior management personnel; (ii) payment of a bonus equal to 150% of the target Bonus
for the calendar year in which such termination occurs pro-rated for the number of days actually worked in the year of termination, payable
within seventy five (75) calendar days following such termination; (iii) the accelerated vesting of the Options, such that the portion
of the Options that was otherwise scheduled to vest during the eighteen (18)&nbsp;month period immediately following such termination
(had Employee remained employed with the Company for that period) will become vested as of the date of Employee&rsquo;s termination; (iv)
the accelerated vesting of RSUs, such that the portion of RSUs that was otherwise scheduled to vest during the eighteen (18) month period
immediately following such termination (had Employee remained employed with the Company for that period) will become vested as of the
date of Employee&rsquo;s termination; (v) the accelerated vesting of PRSUs, such that the portion of PRSUs that was otherwise scheduled
to vest during the eighteen (18) month period immediately following such termination (had Employee remained employed with the Company
for that period) will become vested as of the date of Employee&rsquo;s termination; and (vi) in the event that Employee is enrolled in
any of the Company&rsquo;s group health benefits plans as of the effective date of Employee&rsquo;s termination, then Employee and Employee&rsquo;s
eligible dependents, if any, shall remain eligible to continue their participation in such plans for a period of eighteen (18) months
after Employee&rsquo;s date of termination, subject to the eligibility and other terms and conditions of such plans, except that the Company
will pay the full premiums otherwise payable for such coverage during such 18 month period. Notwithstanding any other provision of this
Agreement, Employee&rsquo;s receipt of Severance Benefits is conditioned on Employee&rsquo;s execution and delivery to the Company of
a separation agreement (that Employee does not revoke) containing a general release, the form and substance of which are acceptable to
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;Unable to Work&rdquo; means the
determination by the Company, following an interactive process, that Employee has become physically or mentally incapable of
performing Employee&rsquo;s essential job functions, with or without a reasonable accommodation, following any period during which
such status would be protected under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee&rsquo;s Initials _____<U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Duties and Responsibilities</U>. Subject to the terms and conditions of this Agreement, Employee will be employed by the Company
as President and Chief Executive Officer or in such other position as may be mutually agreed upon by the parties. A Job Description setting
forth Employee&rsquo;s duties and responsibilities is attached as Exhibit C. Employee accepts such employment, and agrees to perform all
of the duties and accept all of the responsibilities accompanying such position. Employee agrees to serve the Company faithfully and to
the best of Employee&rsquo;s abilities, and to devote all of Employee&rsquo;s business time, skill and attention to such service. Employee
is to be based from a home office and is expected to be available for meetings on a regular basis, upon request by the Company, at the
Company&rsquo;s New Jersey, and Philadelphia, Pennsylvania, locations or such other Company locations as needed including, but not limited
to, the Company&rsquo;s international offices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Full Time and Attention</U>. Employee shall devote Employee&rsquo;s full business time and best efforts to the performance of
Employee&rsquo;s duties and to the furtherance of the Company&rsquo;s interests. During Employee&rsquo;s employment with the Company,
Employee may not hold another position of employment, or be retained as a consultant, or engage in any other business activity (whether
full-time or part-time, whether or not for compensation), unless the Company gives Employee prior written permission to do so. Notwithstanding
anything stated in this provision to the contrary, Employee is permitted to engage in charitable activities, as long as they do not interfere
with Employee&rsquo;s employment obligations to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Policies</U>. During Employee&rsquo;s employment with the Company, Employee will be subject to all applicable employment
and other policies of the Company, as outlined in the Amicus Employee Handbook and as otherwise published by the Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation and Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Base Salary</U>. During Employee&rsquo;s employment, the Company shall pay Employee a salary at the gross annual rate of $ 625,000
(less applicable withholding) or such greater amount as the Board or a committee thereof may from time to time establish pursuant to the
terms hereof (the &ldquo;<U>Base Salary</U>&rdquo;). Such Base Salary shall be reviewed annually and may be increased, but not decreased,
by the Board or a committee thereof in its sole discretion. The Base Salary shall be payable in accordance with the Company&rsquo;s customary
payroll practices for its senior management personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Bonus</U>.
During Employee&rsquo;s employment, Employee shall be eligible to participate in the Company&rsquo;s bonus programs as may be in
effect with respect to senior management personnel. Employee shall be eligible to earn an annual target bonus of 100% of the Base
Salary in cash (the &ldquo;<U>Bonus</U>&rdquo;) such actual amount determined by the Company Compensation Committee in its absolute
discretion and at 60% of base salary; provided, however, that notwithstanding anything to the contrary herein or in any bonus
program, Employee must be employed by the Company as of December 31 of the applicable calendar year, in order to be eligible to earn
a Bonus for such calendar year. Any Bonus payment to which Employee becomes entitled hereunder shall be paid to Employee in a lump
sum (less applicable withholding) on or before the 15<SUP>th</SUP> day of the third month following the end of the calendar year in
which the Bonus was earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee&rsquo;s Initials _____<U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Equity</U>. Subject to the terms and conditions of the Company&rsquo;s Amended and Restated 2007 Equity Incentive Plan and such
other equity plans as the Company may adopt from time to time including, but not limited to, an Employee Stock Purchase Plan, during Employee&rsquo;s
employment with the Company, Employee will be eligible to receive stock options, Restricted Stock Units and Performance Restricted Stock
Units pursuant to any Award Agreement (as that term is defined in the Company&rsquo;s Equity Incentive Plan) between Employee and the
Company. Unless otherwise provided in this Agreement, the terms and conditions of the applicable equity plan will govern all equity grants
to Employee (including vesting of options and units), including with regard to the impact of the end of Employee&rsquo;s employment on
such equity grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Benefit Plans</U>. During Employee&rsquo;s employment, Employee may participate in any benefit plans (including health and medical
insurance) as may be in effect with respect to senior management personnel of the Company, including any equity plan, subject to the eligibility
and contribution requirements, enrollment criteria and other terms and conditions of such plans. The Company reserves the right to modify,
amend and eliminate any such plans, in its sole and absolute discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reimbursement of Expenses</U>. During Employee&rsquo;s employment, the Company shall pay or promptly reimburse Employee, upon
submission of proper invoices or other documentation in accordance with the Company&rsquo;s policies and procedures, for all reasonable
out-of-pocket business, entertainment and travel expenses incurred by Employee in the performance of Employee&rsquo;s duties. Any taxable
reimbursement of business or other expenses as specified under this Agreement shall be subject to the following conditions: (i)&nbsp;the
expenses eligible for reimbursement in one taxable year shall not affect the expenses eligible for reimbursement in any other taxable
year; (ii)&nbsp;the reimbursement of an eligible expense shall be made no later than the end of the calendar year after the year in which
such expense was incurred; and (iii)&nbsp;the right to reimbursement shall not be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vacation</U>. During Employee&rsquo;s employment, Employee shall be entitled to vacation in accordance with the policies of
the Company applicable to senior management personnel as may be in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Withholding</U>. The Company shall withhold from all amounts payable or benefits accorded to Employee all federal, state and
local income, employment and other taxes, as and in such amounts as may be required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____ <U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Duration of Employment. Employee&rsquo;s employment with the Company shall begin on the Effective Date and continue until Employee&rsquo;s
employment is terminated by either Employee or the Company. At all times, Employee&rsquo;s employment with the Company shall be &ldquo;at-will,&rdquo;
meaning that either Employee or the Company may terminate the employment at any time, for no reason or any lawful reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination; Severance Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Termination</U>. Any termination of Employee&rsquo;s employment by the Company or by Employee (other than on account
of death) shall be communicated to the other party by written notice that indicates the specific termination provision in this Agreement
relied upon. Except as otherwise expressly provided in this Agreement or the notice, the termination shall take effect immediately. The
parties agree that the notice requirements set forth in this Agreement do not alter the &ldquo;at will&rdquo; nature of Employee&rsquo;s
employment, as described in <U>Section 4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Generally</U>. Upon termination of Employee&rsquo;s employment for any reason, Employee shall be deemed simultaneously to have
resigned as a member of the Board, if applicable, and from any other position or office Employee may at the time hold with the Company
or any of its Affiliates. Employee agrees to cooperate with the Company by signing any necessary documents and taking any other steps
necessary to effectuate Employee&rsquo;s resignation from the Board, if applicable, and from any other position or office Employee may
hold with the Company or any of its Affiliates. In addition, upon termination of Employee&rsquo;s employment for any reason, the Company
shall pay Employee the Accrued Amounts. The Accrued Amounts will be paid within the time required by applicable law. The impact of the
termination of Employee&rsquo;s employment on the Employee&rsquo;s participation in the Company&rsquo;s health plans is addressed in <U>Section
5.3</U> and <U>Section 5.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by Employee</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resignation Independent of a Change in Control Event</U>. If Employee resigns and a Change in Control Event has not occurred
in the prior 12 months, then (irrespective of whether the resignation was with or without Good Reason): (i)&nbsp;Employee shall receive
no further compensation or remuneration of any kind other than the Accrued Amounts; and (ii)&nbsp;at the end of the month in which the
resignation takes effect, Employee shall cease to be covered under or permitted to participate in or receive any of the benefits described
in <U>Section 3.4</U>, except that, if Employee is enrolled and participating in the Company&rsquo;s health benefit plans at the time
of termination, the Company will allow Employee to continue as a member of those plans at Employee&rsquo;s expense in accordance with
the terms of those plans and the Consolidated Omnibus Budget Reconciliation Act (COBRA) for the legally required benefit continuation
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Good
Reason Resignation Within 12 Months of a Change in Control Event</U>. If Employee resigns for Good Reason within&nbsp;twelve
(12)&nbsp;months after a Change in Control Event, Employee will be entitled to receive, in addition to the Accrued Amounts, Change
in Control Severance Benefits. All payments and benefits under this section, except for the Accrued Amounts, shall: (1)&nbsp;require
Employee to execute and return (and not revoke) a separation agreement containing a general release, the form and substance of which
are acceptable to the Company; and (2)&nbsp;be subject to <U>Section&nbsp;5.6</U> and <U>Section 5.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee&rsquo;s Initials _____<U>/s/</U> <U>BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by the Company</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Without Cause Within 12 Months After a Change in Control Event.</U> If the Company terminates Employee&rsquo;s employment without
Cause within 12 months after a Change in Control Event, then in lieu of any other payments, rights or benefits under <U>Section 5.4(a)</U>,
Employee will be entitled to receive Change in Control Severance Benefits in addition to the Accrued Amounts. All payments and benefits
under this section, except for the Accrued Amounts, shall: (1)&nbsp;require Employee to execute and return (and not revoke) a separation
agreement containing a general release, the form and substance of which are acceptable to the Company; and (2)&nbsp;be subject to <U>Section&nbsp;5.6</U>
and <U>Section 5.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Without Cause Not Within 12 Months After a Change in Control Event</U>. If the Company terminates Employee&rsquo;s employment
without Cause (other than within 12 months after a Change in Control Event), then Employee will be entitled to receive Severance Benefits
in addition to the Accrued Amounts. All payments and benefits under this section, except for the Accrued Amounts, shall: (1)&nbsp;require
Employee to execute and return (and not revoke) a separation agreement containing a general release, the form and substance of which are
acceptable to the Company; and (2)&nbsp;be subject to <U>Section&nbsp;5.6</U> and <U>Section 5.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>For Cause</U>. If the Company terminates Employee&rsquo;s employment for Cause at any time, Employee shall: (i)&nbsp;receive
no further compensation or remuneration of any kind (including any Base Salary or Bonus hereunder) other than the Accrued Amounts; and
(ii)&nbsp;at the end of the month in which the termination takes effect, cease to be covered under or be permitted to participate in or
receive any of the benefits described in <U>Section&nbsp;3.4</U>, except that, if Employee is enrolled and participating in the Company&rsquo;s
health benefit plans at the time of termination, the Company will allow Employee to continue as a member of those plans at Employee&rsquo;s
expense in accordance with the terms of those plans and the Consolidated Omnibus Budget Reconciliation Act (COBRA) for the legally required
benefit continuation period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination upon Death or Inability to Work</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Death.</U> Employee&rsquo;s employment shall terminate immediately upon Employee&rsquo;s death. In the event of Employee&rsquo;s
death during the course of Employee&rsquo;s employment with the Company, the Company will pay the Employee&rsquo;s estate the Accrued
Amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Inability
to Work.</U> Except as otherwise provided by applicable law, the Company may terminate Employee&rsquo;s employment in the event
Employee is Unable to Work. In the event of Employee&rsquo;s death or termination by the Company due to Employee being Unable to
Work, Employee shall receive: (a) the Accrued Amounts, and (b) in the event that Employee is enrolled in any of the Company&rsquo;s
group health benefits plans as of the effective date of Employee&rsquo;s termination, then Employee and Employee&rsquo;s eligible
dependents, if any, shall remain eligible to continue their participation in such plans for a period of twelve (12) months after
Employee&rsquo;s date of termination, subject to the eligibility and other terms and conditions of such plans, except that the
Company will pay the full premiums otherwise payable for such coverage during such 12 month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee&rsquo;s Initials _____<U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General Release and Compliance Required</U>. Employee&rsquo;s receipt of any right, payment or benefit under <U>Section 5.3(b)</U>
or <U>Section 5.4(a)</U> or <U>Section 5.4(b)</U> is subject to and conditioned upon: (a)&nbsp;Employee&rsquo;s execution and delivery
to the Company of a separation agreement (that Employee does not revoke) containing a general release, the form and substance of which
are acceptable to the Company; and (b) Employee&rsquo;s reaffirmation of and continuing compliance with Employee&rsquo;s contractual and
legal obligations to the Company, as expressly set forth in the <FONT STYLE="font-size: 10pt">Confidentiality, Non-Disclosure and Non-Competition
Agreement attached as Exhibit A</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">5.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;409A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Purpose</U>. This section is intended to help ensure that compensation paid or delivered to Employee pursuant to this Agreement
is paid in compliance with, or is exempt from, Section&nbsp;409A of the Code. However, the Company does not warrant to Employee that all
compensation paid or delivered to Employee for Employee&rsquo;s services will be exempt from, or paid in compliance with, Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amounts Payable On Account of Termination</U>. For the purposes of determining when amounts otherwise payable on account of
Employee&rsquo;s termination of employment under this Agreement will be paid, which amounts become due because of Employee&rsquo;s termination
of employment, &ldquo;termination of employment&rdquo; or words of similar import, as used in this Agreement, shall be construed as the
date that Employee first incurs a &ldquo;separation from service&rdquo; for purposes of Section&nbsp;409A on or following termination
of employment. Furthermore, if Employee is a &ldquo;specified employee&rdquo; of a public company as determined pursuant to Section&nbsp;409A
as of Employee&rsquo;s termination of employment, any amounts payable on account of Employee&rsquo;s termination of employment that constitute
deferred compensation within the meaning of Section&nbsp;409A and that are otherwise payable during the first six months following Employee&rsquo;s
termination (or prior to Employee&rsquo;s death after termination) shall be paid to Employee in a cash lump-sum on the earlier of: (i)&nbsp;the
date of Employee&rsquo;s death; or (ii)&nbsp;the first business day of the seventh calendar month immediately following the month in which
Employee&rsquo;s termination occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Series of Payments</U>. Any right to a series of installment payments shall be treated as a right to a series of separate payments
for purposes of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Short-Term
Deferral and Separation Pay Exemptions</U>. Any amounts payable to Employee under this Agreement that meet the requirements for the
 &ldquo;short-term deferral&rdquo; exemption of Treasury Regulation Section 1.409A-1(b)(4) shall be exempt from Section 409A pursuant
to that Regulation, and any amounts payable to Employee under this Agreement that meet the requirements for the &ldquo;involuntary
termination separation pay&rdquo; exemption of Treasury Regulation Section 1.409A-1(b)(9)(iii) shall be exempt from Section 409A
pursuant to that Regulation (the short-term deferral and the involuntary termination separation pay exemptions may be
 &ldquo;stacked&rdquo;). In no event may Employee directly or indirectly designate the calendar year of any payment under this
Agreement. To the extent that amounts payable under this Agreement do not meet the requirements for the short-term deferral
exemption or the involuntary termination separation pay exemption, this Agreement shall be interpreted as satisfying the
requirements of Section 409A for specifying the time and form of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee&rsquo;s Initials _____<U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Participation in Other Severance Plans.</U> Employee agrees and acknowledges that Employee shall not be eligible to participate
in or have any right to compensation or benefits pursuant to the Company&rsquo;s Change in Control Severance Plan (or any successor plan
thereto) or any other Severance Plan issued by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exclusivity</U>. In the event Employee&rsquo;s employment is terminated for any reason, Employee (and Employee&rsquo;s eligible
dependents, if any) shall not be entitled to any payments or benefits from the Company or any of its Affiliates except as specifically
set forth in this <U>Section 5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Federal Excise Tax</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General Rule</U>. Employee&rsquo;s payments and benefits under this Agreement and all other arrangements or programs related
thereto shall not, in the aggregate, exceed the maximum amount that may be paid to Employee without triggering golden parachute penalties
under Section&nbsp;280G of the Code, and the provisions related thereto with respect to such payments. If Employee&rsquo;s benefits must
be cut back to avoid triggering such penalties, to the extent permitted by applicable law and not a violation of Sections 280G or 409A
of the Code, Employee shall be entitled to make a written election for the order in which payments will be reduced.&nbsp; If Employee
does not make a written election, such reduction shall be made in the following order: (i) first, any future cash payments (if any) shall
be reduced (if necessary, to zero); (ii) second, any current cash payments shall be reduced (if necessary, to zero); (iii) third, all
non-cash payments (other than equity or equity derivative related payments) shall be reduced (if necessary, to zero); and (iv) fourth,
all equity or equity derivative payments shall be reduced. If an amount in excess of the limit set forth in this Section is paid to Employee,
Employee must repay the excess amount to the Company upon demand, with interest at the rate provided in Section&nbsp;1274(b)(2)(B) of
the Code. Employee and the Company agree to cooperate with each other reasonably in connection with any administrative or judicial proceedings
concerning the existence or amount of golden parachute penalties on payments or benefits Employee receives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exception</U>. <U>Section 6.1</U> shall apply only if it increases the net amount Employee would realize from payments and benefits
subject to <U>Section&nbsp;6.1</U> after payment of income and excise taxes by Employee on such payments and benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Determinations</U>. The determination of whether the golden parachute penalties under Section&nbsp;280G of the Code and the
provisions related thereto shall be made by counsel chosen by Employee and reasonably acceptable to the Company. All other determinations
needed to apply this <U>Section 6</U> shall be made in good faith by the Company&rsquo;s independent auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____<U>/s/</U> <U>BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Company Computers, Property and Records. Employee agrees to handle all Company property in accordance with the Company&rsquo;s
policies and procedures. Employee&rsquo;s authorization to access the Company&rsquo;s computer systems is limited and use of such systems
to compete or prepare to compete with the Company constitutes unauthorized access that is strictly prohibited. All records received or
created by Employee in the course of employment related to the Company&rsquo;s business (such as but not limited to, email, notes, files,
contact lists, agendas, drawings, maps, specifications, and calendars) are the property of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resolution of Disputes</U>. Employee and the Company hereby agree that, except for disputes regarding alleged or anticipated
violations of the <FONT STYLE="font-size: 10pt">Confidentiality, Non-Disclosure and Non-Competition Agreement attached as <U>Exhibit A</U></FONT>,
any and all disputes between them shall be resolved solely in accordance with the Mutual Agreement to Arbitrate Disputes on an Individual
Basis attached as <U>Exhibit B</U> and, to the greatest extent permitted by law, Employee and the Company expressly waive their respective
right to a trial by jury for any and all such disputes between them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Conflict</U>. Employee represents and warrants that Employee has not entered, nor will Employee enter, into any other agreements
that restrict Employee&rsquo;s ability to fulfill Employee&rsquo;s obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Agreement shall be construed, interpreted and governed by the laws of the state of Employee&rsquo;s
assigned primary office location during the last six months of Employee&rsquo;s employment with the Company, without regard to the conflicts
of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Binding Effect</U>. This Agreement shall extend to and be binding upon Employee, Employee&rsquo;s legal representatives, heirs
and distributees and upon the Company, its successors and assigns regardless of any change in the business structure of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignment</U>. The Company&rsquo;s rights and obligations under this Agreement, including the restrictions in the <FONT STYLE="font-size: 10pt">Confidentiality,
Non-Disclosure and Non-Competition Agreement attached as Exhibit A</FONT>, shall automatically transfer with any sale, transfer or other
disposition of all or substantially all of its assets, stock or business. Employee consents to that transfer. Employee may not assign
any rights or obligations under this Agreement without the Company&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Entire
Agreement</U>. This Agreement contains the entire agreement of the parties with respect to the subject matter hereof and supersedes
all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with
respect thereto<B>, including all Employee&rsquo;s prior Agreements</B>, except this Agreement does not supersede the
Confidentiality, Non-Disclosure and Non-Competition Agreement attached as Exhibit A or the Mutual Agreement to Arbitrate Disputes on
an Individual Basis attached as Exhibit B. Nor does this Agreement supersede any Award Agreement (as that term is defined in the
Company&rsquo;s Equity Incentive Plan) between Employee and the Company. No waiver, modification or change of any provision of this
Agreement shall be valid unless in writing and signed by both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____<U>/s/</U> <U>BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver</U>. The waiver of any breach of any duty, term or condition of this Agreement shall not be deemed to constitute a waiver
of any preceding or succeeding breach of the same or any other duty, term or condition of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If any provision of this Agreement shall be unenforceable in any jurisdiction in accordance with its terms,
the provision shall be enforceable to the fullest extent permitted in that jurisdiction and shall continue to be enforceable in accordance
with its terms in any other jurisdiction and the validity, legality and enforceability of the remaining provisions contained herein shall
not be affected thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. All notices pursuant to this Agreement shall be in writing and shall be sent by prepaid certified mail, return
receipt requested or by recognized air courier service addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1in; width: 10%">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 90%">If to the Company to:</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 1in">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Amicus Therapeutics, Inc.<BR> 3675 Market Street<BR> Philadelphia, PA 19104</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 1.5in">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 1.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">c/o Chief Legal Officer</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 1.5in">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1in">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">If to Employee to:</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 1in">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 1.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Bradley Campbell<BR> at the address identified herein or in Employee&rsquo;s personnel records,</TD>
    </TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to such other addresses as may hereinafter be specified by notice
in writing by either of the parties, and shall be deemed given three (3)&nbsp;business days after the date so mailed or sent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance</U>. If reasonably requested in writing, Employee agrees within fifteen (15) business days to provide the Company
with an executed IRS Form&nbsp;4669 (Statement of Payments Received) with respect to any taxable amount paid to Employee by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which
shall together constitute one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">9.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Knowing
and Voluntary Nature of Agreement</U>. Employee acknowledges and agrees that Employee is executing this Agreement knowingly and
voluntarily and without any duress or undue influence by the Company or anyone else. Employee further acknowledges and agrees that
Employee has carefully read this Agreement and fully understands it. Employee further agrees that Employee has been provided an
opportunity to seek, and has received, the advice of an attorney of Employee&rsquo;s choice (at Employee&rsquo;s expense) before
signing this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____<U>/s/</U> <U>BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties have executed this Agreement on the
date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Bradley Campbell</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Bradley Campbell</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">AMICUS THERAPEUTICS, INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Michael Raab</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name: Michael Raab</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title: Lead Independent Director</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Employee&rsquo;s
Initials _____<U>/s/ BC</U>______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Confidentiality, Non-Disclosure and Non-Competition Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Mutual Agreement to Arbitrate Disputes on an Individual Basis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Job Description</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20220801.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWamBObOdzZR+aYkxtmBybRk6PyEg2MCSZiSco1hmofQD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:fold="http://amicustherapeutics.com/20220801" elementFormDefault="qualified" targetNamespace="http://amicustherapeutics.com/20220801">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://amicustherapeutics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20220801_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20220801_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>fold-20220801_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>fold-20220801_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://amicustherapeutics.com/role/Cover" xlink:href="fold-20220801.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://amicustherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139737075961232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3675 Market Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">921-7600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2222250d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20220801.xsd" xlink:type="simple"/>
    <context id="From2022-08-01to2022-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-08-01to2022-08-01">0001178879</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-08-01to2022-08-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-08-01to2022-08-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-08-01to2022-08-01">2022-08-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-08-01to2022-08-01">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-08-01to2022-08-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-08-01to2022-08-01">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-08-01to2022-08-01">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-08-01to2022-08-01">3675 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-08-01to2022-08-01">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-08-01to2022-08-01">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-08-01to2022-08-01">19104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-08-01to2022-08-01">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-08-01to2022-08-01">921-7600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-08-01to2022-08-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-08-01to2022-08-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-08-01to2022-08-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-08-01to2022-08-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-08-01to2022-08-01">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-08-01to2022-08-01">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-08-01to2022-08-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-08-01to2022-08-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M6.XF%K7>3SR*;:3-"7LZSMB6+[E^RGP%([M2"47"TUS(E"B^F5@>O?[@=DU
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M#H;#P0C!&E58HW.P5NR5+$)@$QL1L-+*3T\LKCB@E\ZP/^KT' 2/.K5U.N<
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M<>BZRMP US=2ZO>!V:Y6_VV8_@M02P,$%     @ 7(D!59^@&_"Q @  X@P
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MB^$_7G\!4$L! A0#%     @ 7(D!50=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !<B0%54E_:'>X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( %R) 567BKL<P    !,"   +
M      "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( %R) 56JQ"(6,P$
M "("   /              "  500  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !<B0%5)!Z;HJT   #X 0  &@              @ &T$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !<B0%599!YDAD!  #/
M P  $P              @ &9$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #C$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2222250d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amicustherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2222250d1_8k.htm">tm2222250d1_8k.htm</File>
    <File>fold-20220801.xsd</File>
    <File>fold-20220801_lab.xml</File>
    <File>fold-20220801_pre.xml</File>
    <File>tm2222250d1_10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2222250d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2222250d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20220801_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20220801_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20220801.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://amicustherapeutics.com/20220801",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2222250d1_8k.htm",
      "contextRef": "From2022-08-01to2022-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://amicustherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2222250d1_8k.htm",
      "contextRef": "From2022-08-01to2022-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-22-084778-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-084778-xbrl.zip
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M7[9LNLNLMX=R1TQP0T(Q'DP6\7</.7S+E0Y,H(Q1<MI:.1A87:05)?YN7+6
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M,I@QL)DH5\Q@K!I"Z!G<D-+<7/@7D7)6.&(C,9EGY\!&F0;M,8'XJ8">P\D
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M>V=:@=;.BA=(Z4\$6^><PA@$\=NHRCJ,G_/I,: 2IP)R;UKK R:O?5WLB'^
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MK'"P4T$N:B;#/4!,'V&1PBR449"V1V-V&)<*'$SW;^2*3K8#G)F'V9)*(.%
M=L!@V2((/?7G#75!-G,;JIPU[?S&JC9=>Q"I/&#EDA2H37Q:(#H^6("*ME#.
M:0J&SC3*G"81@K) ?RP?:R\!R(::0A)_I;)015CI"%=E#9T!&C^J--3*.DJ#
M$L,;@07W1JN *24U"$E7(-G,>AKD385>IFX"<5X@]/+E '?.8L(N_9N N,=K
MB2I9(JG9##2<D6,KHCK/MDN$5\1*/GD%,.G"+I+D:XZ-61I,MAE<0]+!1SM
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MXU[&+;MPZYW>*?^=B7J+3-3VJ+GTO,\"=Z<7%Q711F>:__4'-5FHA'R?.^E
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M,2YX<V102P$"% ,4    " !<B0%5;8>PW?\*  !LAP  %0
M@ %S P  9F]L9"TR,#(R,#@P,5]L86(N>&UL4$L! A0#%     @ 7(D!5?>S
MIJ=<!P  U5@  !4              ( !I0X  &9O;&0M,C R,C X,#%?<')E
M+GAM;%!+ 0(4 Q0    ( %R) 54K\%^J)3(  % L 0 4              "
M 306  !T;3(R,C(R-3!D,5\Q,"TQ+FAT;5!+ 0(4 Q0    ( %R) 57#$A2<
MQ!L  &F)   2              "  8M(  !T;3(R,C(R-3!D,5\X:RYH=&U0
52P4&      4 !0!' 0  ?V0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
